Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia

• Status: Terminated
• Trial end date: 2021-01-30
• Target enrollment: 0
• Participant gender: All

Summary

Steroids has shown benefits in COVID19 patients in observational studies. We hypothesized that early use of corticosteroids, low dose, in mild disease, can decrease progression to respiratory failure and death.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Chile
• Collaborator: Paulette Andino Sarmiento
• Treatments: Prednisone

Criteria

Inclusion Criteria:

• 18 years or more

• COVID-19 confirmed by PCR

• Oxygen requirements until 35 % by venturi mask or 5 lt minutes by nasal cannula

• Consent form signed

Exclusion Criteria:

• Previous steroid use 48 hours or more.

• Pregnancy

• Chronic respiratory failure

• Requirements of mechanical ventilation (invasive or no invasive)

• Chronic liver damage Child Pugh B or C

• Chronic kidney disease stage IV or V.

• Immunosuppressed

• Participation on other trial.